
Keywords: دوز بالا; urinary bladder neoplasms; urothelium; urologic neoplasms; drug therapy; combination; mortality; BCa; bladder cancer; EORTC; European Organization for the Research and Treatment of Cancer; GC; gemcitabine and cisplatin; HD; high dose; MCAVI; methotrexate,